168. エーラス・ダンロス症候群 Ehlers-Danlos syndrome Clinical trials / Disease details
臨床試験数 : 13 / 薬物数 : 21 - (DrugBank : 11) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04890431 (ClinicalTrials.gov) | June 2021 | 6/5/2021 | Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome | Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome: a Randomised Double-blind Placebo-controlled Study | Ehlers-Danlos Syndrome | Drug: Oxygen;Drug: Placebo | Hospital St. Joseph, Marseille, France | NULL | Not yet recruiting | 18 Years | N/A | All | 82 | Phase 4 | NULL |